We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-27.88%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.32B
AUM Growth
-$346M
(-21%)
Cap. Flow
-$15.1M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
59.82%
Holding
111
New
34
Increased
24
Reduced
9
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$69.5M |
| 2 |
Energizer
ENR
|
+$56.7M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$40.3M |
| 4 |
SGI
Somnigroup International
SGI
|
+$34.7M |
| 5 |
WBT
Welbilt, Inc.
WBT
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$37.3M |
| 2 |
Harley-Davidson
HOG
|
+$37.3M |
| 3 |
HBI
Hanesbrands
HBI
|
+$36.9M |
| 4 |
Capri Holdings
CPRI
|
+$36.7M |
| 5 |
Avis
CAR
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.78% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Industrials | 7.52% |
| 4 | Consumer Staples | 5.7% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Capri Holdings
CPRI
$1.83B
| – | – |
-536,000
| Closed | -$36.7M |
|
|
DESP
77
DELISTED
Despegar.com
DESP
| – | – |
-1,564,000
| Closed | -$26.4M |
|
78
Brinker International
EAT
$9.17B
| – | – |
-200,000
| Closed | -$9.35M |
|
79
Floor & Decor
FND
$6.22B
| – | – |
-300,000
| Closed | -$9.05M |
|
80
CALL
Hain Celestial
HAIN
$45M
| – | – |
-2,000,000
| Closed | -$54.2M |
|
|
81
Hain Celestial
HAIN
$45M
| – | – |
-1,000,000
| Closed | -$27.1M |
|
|
HBI
82
DELISTED
Hanesbrands
HBI
| – | – |
-2,000,000
| Closed | -$36.9M |
|
|
83
Harley-Davidson
HOG
$2.58B
| – | – |
-824,000
| Closed | -$37.3M |
|
84
CALL
Incyte
INCY
$24.2B
| – | – |
-700,000
| Closed | -$48.4M |
|
|
LNW
85
DELISTED
Light & Wonder
LNW
| – | – |
-900,000
| Closed | -$22.9M |
|
86
lululemon athletica
LULU
$13.5B
| – | – |
-50,000
| Closed | -$8.13M |
|
87
Madrigal Pharmaceuticals
MDGL
$10.8B
| – | – |
-80,000
| Closed | -$17.1M |
|
88
Medifast
MED
$109M
| – | – |
-24,000
| Closed | -$5.32M |
|
89
Meta Platforms (Facebook)
META
$1.42T
| – | – |
-50,000
| Closed | -$8.22M |
|
90
PetMed Express
PETS
$41.7M
| – | – |
-532,000
| Closed | -$17.6M |
|
91
Ralph Lauren
RL
$22.6B
| – | – |
-218,000
| Closed | -$30M |
|
|
FLNA
92
Filana Therapeutics
FLNA
$48.8M
| – | – |
-2,164,000
| Closed | -$2.19M |
|
93
AT&T
T
$159B
| – | – |
-132,400
| Closed | -$3.36M |
|
|
TTNP
94
DELISTED
Titan Pharmaceuticals
TTNP
| – | – |
-61
| Closed | -$46K |
|
|
95
United Therapeutics
UTHR
$25.8B
| – | – |
-292,000
| Closed | -$37.3M |
|
96
Vanda Pharmaceuticals
VNDA
$307M
| – | – |
-900,000
| Closed | -$20.7M |
|
|
VXRT
97
DELISTED
Vaxart
VXRT
| – | – |
-150,000
| Closed | -$428K |
|
|
GAP
98
The Gap Inc
GAP
$7.23B
| – | – |
-524,000
| Closed | -$15.1M |
|
|
QVCGA
99
DELISTED
QVC Group Inc Series A
QVCGA
| – | – |
-18,540
| Closed | -$20M |
|
|
CMRX
100
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-1,300,000
| Closed | -$5.06M |
|
Similar funds
CRC
RMDI
F
DCP
EW
O
PA
DSC
Armistice Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Armistice Capital held 111 positions worth $1.32B, down 21% from $1.67B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Armistice Capital's Q4 2018 filing shows 34 new, 24 increased, 9 reduced and 40 closed positions. Its largest new stake was Energizer: 1,068,000 shares worth $48.2M. The largest sale was United Therapeutics, an estimated $37.3M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Armistice Capital's largest Q4 2018 buy was Energizer: 1,068,000 shares worth $48.2M.
- Armistice Capital added most to Clovis Oncology, Inc. in Q4 2018, an estimated $69.5M increase.
- Armistice Capital's biggest Q4 2018 reduction was J.M. Smucker, cutting an estimated $28.8M.
- Armistice Capital fully exited United Therapeutics in Q4 2018, selling an estimated $37.3M.
- Armistice Capital's ten largest holdings make up 60% of its $1.32B portfolio in Q4 2018.
- Armistice Capital opened 34 new positions and closed 40 in Q4 2018.
- Armistice Capital's portfolio value fell 21% quarter-over-quarter to $1.32B.
Based on Armistice Capital's 13F filing for Q4 2018, filed 14 Feb 2019.